ArticleStatistics in medicine2026
Reluctant Transfer Learning in Penalized Regressions for Individualized Treatment Rules Under Effect Heterogeneity.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Estimating individualized treatment rules (ITRs) is fundamental to precision medicine, where the goal is to tailor treatment decisions to individual patient characteristics. While numerous methods have been developed for ITR estimation, there is limited research on model updating that accounts for shifted treatment-covariate relationships in the ITR setting. In practice, models trained on source data must be updated for new (target) datasets that exhibit shifts in treatment effects. To address this challenge, we propose a reluctant transfer learning (RTL) framework that enables efficient model adaptation by selectively transferring essential model components (e.g., regression coefficients) from source to target data, without requiring access to individual-level source data. Leveraging the principle of reluctant modeling, the RTL approach incorporates model adjustments only when they improve performance on the target dataset, thereby controlling complexity and enhancing generalizability. Our method supports multi-armed treatment settings, performs variable selection for interpretability, and provides a regret bound for the difference in value of the optimal ITR and that of the estimated ITR. Through simulation studies and an application to a real data example from the Best Apnea Interventions for Research (BestAIR) trial, we demonstrate that RTL outperforms existing alternatives. The proposed framework offers an efficient, practically feasible approach to adaptive treatment decision-making under evolving treatment effect conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.